documents: FDA-2010-P-0614-0056

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-P-0614-0056 FDA FDA-2010-P-0614 Tab 18 - "FDA/CDER Chemistry Review(s) for NDA 21-292, Novothyrox (levothyroxine sodium tablet, USP)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:38Z   0 0 0900006480c27c6b

Links from other tables